Keyphrases
Confidence Interval
100%
Hazard Ratio
100%
Angiotensin-converting Enzyme Inhibitor (ACEi)
100%
Angiotensin Receptor Blockers
100%
Maintenance Hemodialysis Patients
100%
Uremic Patients
100%
Vascular Access Patency
100%
Calcium Channel Blockers
100%
Arteriovenous Fistula
66%
Arteriovenous Graft
66%
Primary Patency
50%
Taiwan
16%
National Health Insurance Research Database (NHIRD)
16%
Patient Characteristics
16%
Comorbidity
16%
Cox Proportional Hazards Model
16%
Prospective Randomized Trial
16%
Maintenance Hemodialysis
16%
Cardioprotection
16%
Pharmacotherapy
16%
Vascular Graft Infection
16%
Long-term Hemodialysis
16%
Access Thrombosis
16%
Co-medication
16%
Dialysis Access
16%
Nursing and Health Professions
Hemodialysis
100%
Confidence Interval
100%
Hazard Ratio
100%
Vascular Access
100%
Dipeptidyl Carboxypeptidase Inhibitor
100%
Angiotensin Receptor Antagonist
100%
Calcium Channel Blocking Agent
100%
Arteriovenous Fistula
66%
Arteriovenous Graft
66%
National Health Insurance
16%
Drug Therapy
16%
Proportional Hazards Model
16%
Thrombosis
16%
Antihypertensive Agent
16%
Comorbidity
16%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
100%
Hemodialysis
100%
Angiotensin Receptor
100%
Patency
100%
Enzyme Inhibitor
100%
Calcium Channel Blocker
100%
Comorbidity
14%
Drug Therapy
14%
Pharmacology, Toxicology and Pharmaceutical Science
Dipeptidyl Carboxypeptidase Inhibitor
100%
Angiotensin Receptor Antagonist
100%
Hemodialysis
100%
Calcium Channel Blocker
100%
Arteriovenous Fistula
66%
Pharmacotherapy
16%
Thrombosis
16%
Antihypertensive Agent
16%
Comorbidity
16%